Daprodustat Patent Expiration
Daprodustat is Used for managing anemia associated with chronic kidney disease. It was first introduced by Glaxosmithkline Intellectual Property No 2 Ltd England
Daprodustat Patents
Given below is the list of patents protecting Daprodustat, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Jesduvroq | US11117871 | Crystalline forms of GSK1278863, preparation method and pharmaceutical use thereof | Mar 13, 2038 | Glaxosmithkline |
| Jesduvroq | US11643397 | Prolyl hydroxylase inhibitors | Jun 22, 2027 | Glaxosmithkline |
| Jesduvroq | US11649217 | Crystalline forms of GSK1278863, preparation method and pharmaceutical use thereof | Mar 13, 2038 | Glaxosmithkline |
| Jesduvroq | US8324208 | Prolyl hydroxylase inhibitors | Dec 11, 2028 | Glaxosmithkline |
| Jesduvroq | US8557834 | Prolyl hydroxylase inhibitors | Jun 22, 2027 | Glaxosmithkline |
| Jesduvroq | US8815884 | Prolyl hydroxylase inhibitors | Jun 22, 2027 | Glaxosmithkline |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳